Alnylam’s Onpattro is first ever FDA-approved RNAi drug
Onpattro will cost $450,000 a year
X
Alnylam’s Onpattro is first ever FDA-approved RNAi drug
https://pharmaphorum.com/news/alnylams-onpattro-first-ever-approved-rnai-drug/
Alnylam
AZ grabs licence as Ionis NASH drug heads to the clinic
Could antisense drug be a fatty liver disease blockbuster?
AZ signs kidney drug deal with Ionis for up to $330m
Deal is result of six-year collaboration with AZ
1 2
